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1. Introduction 
Actually, more than 30 million people are affected with human immunodeficiency virus 
(HIV) infection worldwide [1]. Since the introduction of the highly active antiretroviral 
therapy (HAART) at the end of 1995, overall mortality of patients with HIV infection 
decreased dramatically as well as mortality caused by HIV infection or by an Acquired 
Immunodeficiency Syndrome (AIDS)-defining disease. Conversely, mortality due to kidney 
disease, liver disease, heart disease, and non-AIDS-defining cancers has proportionally 
increased [2,3,4].  
Renal disorders in HIV-infected patients can present as an acute or chronic condition and 
they are associated with increased morbidity and mortality in this population [5,6,7,8,9]. 
Acute kidney injury is a common complication in ambulatory HIV-infected patients 
treated with HAART and has been associated with prior renal impairment, lower CD4 
levels, AIDS, hepatitis C virus (HCV) co-infection, and liver disease [10,11]. HIV-infected 
patients are also at increased risk for AKI development within hospitalization, related to 
volume depletion, sepsis, and the acute administration of nephrotoxic medications or 
radiocontrast. Before the advent of HAART, studies addressing AKI on HIV-infected 
patients typically included only severe cases of AKI which were identified through 
hospital records or biopsy databases [12,13,14]. The epidemiology of AKI in hospitalized 
HIV-infected patients in the HAART era has also not been extensively analyzed. In fact, 
few studies have focused on the clinical characteristics of AKI in hospitalized HIV-
infected patients in the HAART era [15,16,17,18]. In this chapter, we provide a critical and 
contemporary review of AKI in hospitalized HIV-infected patients in the HAART era, 
focusing on the incidence, risk factors, and outcome. 
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2. Incidence of AKI in hospitalized HIV-infected patients  
Three recent studies 15,16,17 have addressed specifically the incidence of AKI in 
hospitalized HIV-infected patients (Table 1). Wyatt et al 15 compared the incidence of AKI 
in HIV-infected patients before and after the introduction of HAART. For this purpose, all 
adult patients who were discharged from acute care hospitals in New York State during 
1995 (pre-HAART era) and during 2003 (post-HAART era) were evaluated. The presence of 
AKI was determined by a diagnosis code 584 of the International Classification of Diseases, 
9th Revision (ICD-9), which identified AKI based on the clinical judgement of the treating 
physician. There were 52.580 patients with documented HIV infection discharged from 
hospital in 1995, and 25.114 in 2003. Acute kidney injury was reported significantly more 
often during hospitalizations for HIV-infected patients than for uninfected patients in both 
2003 (6% versus 2.7%) and 1995 (2.9% versus 1.0%). After adjusting for other covariates, HIV 
infection remained associated with an increased risk of AKI both in 2003 [adjusted odds 
ratio (OR) 2.82, 95% confidence interval (CI) 2.66-2.99) and in 1995 (adjusted OR 4.62, 95% CI 
4.3-4.95). Lopes et al 16 conducted a cohort study including 489 HIV-infected patients 
hospitalized in a tertiary and teaching Portuguese Hospital between 2005 and 2007 to 
characterize AKI in this population. Acute kidney injury was defined and categorized 
according to "Risk Injury Failure Loss of kidney function End-stage kidney disease" (RIFLE) 
classification [19], and it was considered if there was an increase of baseline serum 
creatinine × 1.5 or in patients with baseline serum creatinine > 4 mg/dl if there was an acute 
rise in serum creatinine of at least 0.5 mg/dl. They found that 18% of patients had AKI 
within the hospitalization which was much higher than the incidence previously reported 
(6%) in hospitalized HIV-infected patients in HAART era 15. It should be remembered that 
in the study of Wyatt et al 15 the diagnosis of AKI was determined by a diagnosis code 584 
of the ICD-9 based on the clinical judgement and documentation of the treating physician, 
and laboratory values were not reported. Administrative databases may be a powerful tool 
for the study of AKI, although the low sensitivity of the AKI codes still remains an 
important caveat 20. Therefore, in the study of Wyatt et al 15 the utilization of diagnostic 
code to identify AKI could not have captured an important number of cases. 
In a previous report, Lopes et al 17 have also studied AKI in a small cohort of critically ill 
HIV-infected patients hospitalized in a tertiary and teaching Portuguese Hospital between 
2002 and 2006. In this retrospective study, 47% of patients had AKI (defined by the RIFLE 
criteria) during the intensive care unit (ICU) stay. 
3. Risk factors of AKI in hospitalized HIV-infected patients  
In the HAART era, clinical conditions commonly associated with increased risk of AKI in 
the general population such as older age, Male, Black race, diabetes, prior hypertension, 
liver disease and pre-existing chronic kidney disease have also been reported as 
independent risk factors of AKI in hospitalized HIV-infected patients 15,16,17 (Table 1). 
Accordingly, renal function should be closely monitored during the hospitalization, and an 
adequate control of glycemia and blood pressure as well as the appropriate management of 
patients with acute or chronic liver insufficiency and/or chronic kidney disease could 
prevent the occurrence of AKI.  
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 N Design Setting 
Year of 
hospitalization
Definition 
of AKI 
Incidence 
of AKI 
Risk factors of 
AKI 
Mortality 
(AKI versus 
non-AKI) 
Wyatt et 
al 15 25.114 
Retrospective, 
multicenter 
Hospitalized 2003 
Code 584 
of the 
ICD-9 
6% 
Age (per year 
above mean) 
(adjusted OR 1.03, 
95% CI, 1.02-1.04), 
Male (adjusted 
OR 1.16, 95% CI 
1.04-1.30), 
diabetes mellitus 
(adjusted OR 1.27, 
95% CI 1.08-1.49), 
chronic kidney 
disease (adjusted 
OR 5.48, 95% CI 
4.58-6.56), liver 
disease (adjusted 
OR 1.59, 95% CI 
1.40-1.79) 
In-hospital 
mortality 
27% versus 
4.5% 
(adjusted OR 
5.83; 95% CI, 
5.11-6.65, 
P0.0001) 
Lopes et 
al 16 489 
Retrospective, 
single-center 
Hospitalized 2005-2007 
1.5X 
SCr or 
SCr 
≥0.5mg (if 
baseline 
SCr 
4mg/dl)
18% 
Pre-existing 
hypertension 
(adjusted OR 2.4, 
95% CI 1.04-5.6, 
P=0.04), AIDS 
(adjusted OR 2.7, 
95% CI 1.2-6, 
P=0.02), sepsis 
(adjusted OR 23, 
95% CI 11-45.3, 
P<0.001), and 
nephrotoxic 
drugs 
administration 
(adjusted OR 2.8, 
95% CI 1.4-5.8, 
P=0.004) 
In-hospital 
mortality 
27.3% 
versus 8% 
(adjusted OR 
2.7, 95% CI 
1.3-5.6, 
P=0.008) 
Lopes et 
al 17 97 
Retrospective, 
single-center 
Intensive 
care unit 
2002-2006 
1.5X 
SCr or 
SCr 
≥0.5mg (if 
baseline 
SCr 
4mg/dl)
47% 
Age >60 years 
(adjusted OR 5.32, 
95% CI 1.23-23, 
P=0.025), HCV 
co-infection 
(adjusted OR 3.42, 
95% CI 1.08-10.85, 
P=0.037), SAPS II 
>50 (adjusted OR 
2.35, 95% CI 1.2-
5.9, P=0.008) 
60-day 
mortality 
(65% versus 
24%, 
P0.0001) 
Table 1. Studies reporting the incidence, risk factors and mortality of acute kidney injury in 
the highly active antiretroviral therapy era. AKI- acute kidney injury. ICD-9- International 
Classification of Diseases, 9th Revision. OR- odds ratio. CI- confidence interval. HCV- 
hepatitis C virus. SCr- serum creatinine. AIDS- Acquired Immunodeficiency Syndrome. 
SAPS II- Simplified Acute Pathophysiology Score version II. 
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Hepatitis C virus co-infection has also been associated with increased risk for AKI (Table 1). 
Hepatitis C virus co-infection is an increasingly important cause of morbidity and mortality 
in patients with HIV [2, and affects approximately 30% of HIV-infected individuals [21. 
Studies have demonstrated that co-infection with HIV and HCV translates into higher 
morbidity and mortality related to end-stage liver disease [22. A recent meta-analysis of 27 
studies including data of more than 18.000 HIV-infected patients has also demonstrated that 
HCV co-infection was associated with an increased risk of AKI by 64% [23. Therefore, the 
association between HCV co-infection and risk for acute and chronic kidney disease 
supports existing guidelines for the diagnosis and management of kidney disease in patients 
with HIV [5. 
Only two studies have specifically analyzed the etiology of AKI in hospitalized HIV-
infected patients 16,17. In the study of Lopes et al 16, the etiology of AKI was 
multifactorial in 48.9% of patients. The most common etiologies of AKI in this cohort were 
sepsis (59%), nephrotoxic drugs administration (i.e. aminoglycosides, amphotericine B, 
vancomycin, acyclovir, gancyclovir and foscarnet) (37.5%), volume depletion (21.6%), and 
use of radiocontrast (20.5%). Other less common causes of AKI were tumour lysis syndrome, 
hemorrhage, acute urinary tract obstruction and thrombotic microangiopathy. In the ICU 
setting, Lopes et al 17 have also identified sepsis as the most common cause of AKI (86%) 
in HIV-infected patients. Therefore, prompt recognition and aggressive treatment of sepsis, 
adequate hydration, avoidance and serum monitoring of nephrotoxic drugs, and 
prophylaxis of contrast induced nephropathy could be important in diminishing the 
occurrence of AKI in this population [24,25]. 
The influence of HIV-related variables namely type of HIV, HAART, CD4 lymphocyte 
count, viral load and AIDS diagnosis in the development of AKI in hospitalized HIV-
infected patients still remains to be established. In fact, only one study has attempted to 
study the impact of those variables on renal function in hospitalized HIV-infected patients 
16. In this study, only AIDS-defining conditions were independently associated with AKI 
and none association was found with type of HIV, HAART, CD4 lymphocyte count and 
viral load. However, the limited number of studied patients did not allow the authors to 
conclude definitively about the influence of those variables in the development of AKI. 
Therefore, prospective and randomized studies with a large number of patients are still 
warranted to better determine the precise impact of those HIV-related variables on renal 
function among HIV-infected patients who are hospitalized.  
4. Impact on outcome of AKI in hospitalized HIV-infected patients  
Acute kidney injury is a risk factor for short- and long-term mortality, and there is a 
graded relationship between severity of AKI and increased mortality 
[26,27,28,29,30,31,32]. The mechanism by which AKI contributes to increased mortality is 
not completely understood. Volume overload, coagulation abnormalities, an increased 
incidence of sepsis with multi-organ failure, and cytokine or immunemediated major 
organ dysfunction are other possible explanations for poor survival among AKI patients. 
The permanent injury to other vital organs caused by AKI, although the potential 
reversible nature of clinical AKI, in which serum creatinine can return to baseline after the 
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acute episode, could account for decreased long-term survival of patients who developed 
AKI [33,34,35]. Moreover, CKD disease with subsequent hypertension, proteinuria and 
increased cardiovascular disease has been appointed as a possible cause of poor long-term 
outcome among AKI patients [36]. 
The development of AKI during the hospitalization also portends an ominous outcome 
among HIV-infected patients (Table 1). In the study of Wyatt et al 15, hospitalizations of 
HIV-infected patients that were complicated by AKI were also complicated by much higher 
in-hospital mortality that seen in admissions of HIV-infected patients without AKI and, 
furthermore, AKI independently increased in-hospital mortality of those patients. In the 
study of Lopes et al 16, the development of AKI was associated with lengthened time of 
hospitalization and increased in-hospital mortality. In fact, patients who developed AKI 
within the hospitalization had higher in-hospital mortality than those patients who did not 
develop AKI. After adjusting for other covariates, AKI still remained associated with 
increased in-hospital mortality. Furthermore, there was a relationship between more severe 
AKI and increased in-hospital mortality. In critically ill HIV-infected patients 17, AKI has 
also been associated with increased mortality, and there was a graded relationship between 
AKI severity and mortality.  
The detrimental impact of AKI on patient outcome seems to persist after hospital discharge 
even in those patients who exhibit renal function recovery. Recently, Choi et al 17 
conducted an observational cohort study in a national sample of 17.325 HIV-infected 
persons receiving care in the Veterans Health Administration who survived at least 90 days 
after discharge from their first hospitalization to examine the association between AKI 
experienced during their first hospitalization with the development of heart failure, 
atherosclerotic cardiovascular events, end-stage renal disease (ESRD), and death over a 
period of 2 decades. They found a graded and independent association between severity of 
AKI with heart failure, cardiovascular disease, ESRD, and death.  
5. Conclusions 
Acute kidney injury is a common complication in hospitalized HIV-infected patients in the 
HAART era. Older patients, Male, Black race patients, diabetic and /or hypertensive 
patients and patients with pre-existing chronic kidney disease, HCV co-infection and/or 
liver disease are at increased risk for AKI within the hospitalization and, therefore, renal 
function should be closely monitored in those patients. Sepsis is the most common etiology 
of AKI in this setting and should be promptly diagnosed and treated. The occurrence of AKI 
is associated with both increased short- and long-term mortality. Therefore, prevention of 
AKI should be an important task to accomplish in order to improve morbidity and mortality 
in this specific population.  
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